Literature DB >> 24357325

Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis.

Murray Baron1, Lorinda Chung, Geneviève Gyger, Laura Hummers, Dinesh Khanna, Maureen D Mayes, Janet E Pope, Ami A Shah, Virginia D Steen, Russell Steele, Solène Tatibouet, Ariane Herrick, Ulf Müller-Ladner, Marie Hudson.   

Abstract

The objectives of this study were to develop a standard classification of digital ulcers (DUs) in systemic sclerosis (SSc) for use in observational or therapeutic studies and to assess the reliability of these definitions as well as of the measurement of ulcer area. Ten North American rheumatologists with expertise in SSc reviewed multiple photos of DUs, examined four SSc subjects with DUs, and came to a consensus on the definitions for digital, active, healed, and indeterminate ulcers. These ten raters then examined the right hand of ten SSc subjects twice and the left hand once to classify ulcers and to measure ulcer area. Weighted and Fleiss kappa were used to calculate intra- and interrater agreement on classification of ulcers, and intraclass correlation coefficient (ICC) was used to assess agreement on ulcer area. Because the traditional ICC calculations relied on a small number of ulcers, ICCs were recalculated using the results of linear mixed models to evaluate the variance components of observations on all the data. Intrarater kappa for classifying DU as not an ulcer/healed ulcer versus active/indeterminate ulcer was substantial (0.76), and interrater kappa was moderate (0.53). The ICC for ulcer area using the linear mixed models was moderate both for intrarater (0.57) and interrater (0.48) measurements. A consensus for the classification of DUs in SSc was developed, and after a training session, rheumatologists with expertise in SSc are able to reliably classify DUs and to measure ulcer area.

Entities:  

Mesh:

Year:  2013        PMID: 24357325     DOI: 10.1007/s10067-013-2460-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

Review 1.  Digital ulcers in patients with systemic sclerosis.

Authors:  Lorinda Chung; David Fiorentino
Journal:  Autoimmun Rev       Date:  2005-09-13       Impact factor: 9.754

2.  Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

Authors:  J H Korn; M Mayes; M Matucci Cerinic; M Rainisio; J Pope; E Hachulla; E Rich; P Carpentier; J Molitor; J R Seibold; V Hsu; L Guillevin; S Chatterjee; H H Peter; J Coppock; A Herrick; P A Merkel; R Simms; C P Denton; D Furst; N Nguyen; M Gaitonde; Carol Black
Journal:  Arthritis Rheum       Date:  2004-12

3.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

4.  Efficacy of tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial.

Authors:  Padmanabha D Shenoy; Sudeep Kumar; Lalan K Jha; Sunil K Choudhary; Uttam Singh; Ramnath Misra; Vikas Agarwal
Journal:  Rheumatology (Oxford)       Date:  2010-09-12       Impact factor: 7.580

5.  Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis.

Authors:  Vanessa L Malcarne; Ingunn Hansdottir; Ann McKinney; Renn Upchurch; Helen L Greenbergs; Gretchen H Henstorf; Daniel E Furst; Philip J Clements; Michael H Weisman
Journal:  J Rheumatol       Date:  2007-02       Impact factor: 4.666

6.  Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.

Authors:  Anna Abou-Raya; Suzan Abou-Raya; Madihah Helmii
Journal:  J Rheumatol       Date:  2008-08-15       Impact factor: 4.666

7.  The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time.

Authors:  V D Steen; T A Medsger
Journal:  Arthritis Rheum       Date:  1997-11

8.  Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis.

Authors:  Ariane L Herrick; Christopher Roberts; Andrew Tracey; Alan Silman; Marina Anderson; Mark Goodfield; Neil McHugh; Lindsay Muir; Christopher P Denton
Journal:  Arthritis Rheum       Date:  2009-03

9.  Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.

Authors:  Marco Matucci-Cerinic; Christopher P Denton; Daniel E Furst; Maureen D Mayes; Vivien M Hsu; Patrick Carpentier; Fredrick M Wigley; Carol M Black; Barri J Fessler; Peter A Merkel; Janet E Pope; Nadera J Sweiss; Mittie K Doyle; Bernhard Hellmich; Thomas A Medsger; Adele Morganti; Fabrice Kramer; Joseph H Korn; James R Seibold
Journal:  Ann Rheum Dis       Date:  2010-08-30       Impact factor: 19.103

  9 in total
  17 in total

1.  High-resolution ultrasound of peripheral nerves in systemic sclerosis: a pilot study of computer-aided quantitative assessment of nerve density.

Authors:  Bianca Bignotti; Massimo Ghio; Nicoletta Panico; Giulio Tagliafico; Carlo Martinoli; Alberto Tagliafico
Journal:  Skeletal Radiol       Date:  2015-08-12       Impact factor: 2.199

2.  Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1).

Authors:  Christopher A Mecoli; Jamie Perin; Jennifer E Van Eyk; Jie Zhu; Qin Fu; Andrew G Allmon; Youlan Rao; Scott Zeger; Fredrick M Wigley; Laura K Hummers; Ami A Shah
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

Review 3.  Patient-reported outcome instruments in clinical trials of systemic sclerosis.

Authors:  John D Pauling; Joana Caetano; Corrado Campochiaro; Giacomo De Luca; Ana Maria Gheorghiu; Maria Grazia Lazzaroni; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2019-11-25

4.  The critical need for accurately defining digital ulcers in scleroderma.

Authors:  Wendy Li; Tracy M Frech
Journal:  J Scleroderma Relat Disord       Date:  2017-05-19

5.  Serum level of endostatin and digital ulcers in systemic sclerosis patients.

Authors:  Antonietta Gigante; Domenico Margiotta; Luca Navarini; Biagio Barbano; Maria L Gasperini; Claudia D'Agostino; Antonio Amoroso; Antonella Afeltra; Edoardo Rosato
Journal:  Int Wound J       Date:  2018-03-30       Impact factor: 3.315

6.  Digital ulcer debridement in systemic sclerosis: a systematic literature review.

Authors:  Michael Hughes; Begonya Alcacer-Pitarch; Ana Maria Gheorghiu; Emanuela Praino; Robert David Sandler; Yonit Tavor; Cosimo Bruni; Marco Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2020-01-18       Impact factor: 2.980

7.  Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition.

Authors:  Y A Suliman; C Bruni; S R Johnson; E Praino; M Alemam; N Borazan; L Cometi; B Meyers; D Khanna; Y Allanore; M Baron; T Krieg; A Herrick; A Afonso; O Distler; S Kafaja; C P Denton; M Matucci-Cerinic; D E Furst
Journal:  J Scleroderma Relat Disord       Date:  2017-05-19

Review 8.  Optimal management of digital ulcers in systemic sclerosis.

Authors:  Shawn Abraham; Virginia Steen
Journal:  Ther Clin Risk Manag       Date:  2015-06-15       Impact factor: 2.423

9.  Review of local wound management for scleroderma-associated digital ulcers.

Authors:  Nicholas Lebedoff; Tracy M Frech; Victoria K Shanmugam; Aryeh Fischer; Daniel Erhardt; Jason Kolfenbach; Kevin Kohler; Kurt Bernhisel; Giavonni M Lewis
Journal:  J Scleroderma Relat Disord       Date:  2017-11-17

10.  Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: A challenge for clinical trial design.

Authors:  Michael Hughes; Andrew Tracey; Monica Bhushan; Kuntal Chakravarty; Christopher P Denton; Shirish Dubey; Serena Guiducci; Lindsay Muir; Voon Ong; Louise Parker; John D Pauling; Athiveeraramapandian Prabu; Christine Rogers; Christopher Roberts; Ariane L Herrick
Journal:  J Scleroderma Relat Disord       Date:  2018-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.